Press Releases Archives

Instem Strengthens Commitment to End-to-End Preclinical Platform Amid Regulatory Evolution

Instem is reaffirming its role as the industry’s trusted provider of an end-to-end preclinical platform.

The latest release introduces advanced features to enhance toxicity prediction, improve data integration, and support in silico safety assessments.

Streamlining Pathology Workflows with Modern, Integrated Tools

Instem welcome the Trimetra team.

Powerful study management updates provide cutting-edge digital pathology capabilities.

Advance™ technology-enabled solution enables R&D organizations to cut study timelines, deliver cost savings and reduce animal experimentation.

Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.

New Software Module Introduced to Support the Latest Regulatory-approved Carcinogenic Potency Categorization Approach (CPCA)

New powerful technology and data sharing suite provides a range of translational science solutions

New functionality along with Enhanced Models to Deliver More Efficient and Comprehensive Predictions in Chemical Safety